Presentations we supply
- Injection 40 mg
- Injection 100 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for IrinotecanReference information
Summarised from the product information for Irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion (UK product information). Always follow the product information approved in your own country.
- Active substance
- Irinotecan
- Pharmacotherapeutic group
- Cytostatic topoisomerase I inhibitor (ATC code L01CE02)
- Authorised uses
- Advanced colorectal cancer not previously treated with chemotherapy, with 5-fluorouracil and folinic acid
- Advanced colorectal cancer as a single agent, after a 5-fluorouracil regimen has failed
- EGFR-expressing, RAS wild-type metastatic colorectal cancer, with cetuximab
- First-line metastatic colorectal cancer, with 5-fluorouracil, folinic acid and bevacizumab
- First-line metastatic colorectal cancer, with capecitabine, with or without bevacizumab
- Storage (unopened)
- Keep the vial in the outer carton in order to protect from light. Do not freeze.
- Shelf life (unopened)
- 3 years (unopened vial)
- Container and pack
- Type I amber glass vials of 40 mg/2 ml, 100 mg/5 ml, 300 mg/15 ml or 500 mg/25 ml with flip-off cap; pack of 1 vial
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion: www.medicines.org.uk